Correction to: COVID-19 Outcomes and Vaccination in People with Relapsing Multiple Sclerosis Treated with Ofatumumab (Neurology and Therapy, (2022), 11, 2, (741-758), 10.1007/s40120-022-00341-z)

Anne H. Cross, Silvia Delgado, Mario Habek, Maria Davydovskaya, Brian J. Ward, Bruce A.C. Cree, Natalia Totolyan, Ratnakar Pingili, Linda Mancione, Xixi Hu, Roseanne Sullivan, Wendy Su, Ronald Zielman, Ayan Das Gupta, Xavier Montalban, Kevin Winthrop

Research output: Contribution to journal › Comment/debate › peer-review

Fingerprint

Dive into the research topics of 'Correction to: COVID-19 Outcomes and Vaccination in People with Relapsing Multiple Sclerosis Treated with Ofatumumab (Neurology and Therapy, (2022), 11, 2, (741-758), 10.1007/s40120-022-00341-z)'. Together they form a unique fingerprint.

Medicine & Life Sciences